GWAS of GLP1 medication efficacy We performed a GWAS of the percentage BMI loss phenotype ( n = 15,237), and identified a strong genome-wide significant association on chromosome (chr.) 6 (Fig
Health Improvements: Besides weight, retatrutide improved metabolic health markers
A medication that reduces alcohol consumption as a side effect of treatment for other conditions like obesity could reach this population in ways that traditional addiction treatments cannot
This approach simplifies the quest for an ideal maintenance dose, supports results in the long term, and manages changes occurring along the way
In addition, variable comparators such as metformin or insulin have important differences, because insulin is known to cause weight gain
It is important to consult with a healthcare provider to determine if semaglutide is the right medication for you